Microgentas specializes in integrated exosome isolation and miRNA extraction technologies. The company addresses sample preparation challenges through its suite of core technologies, delivering faster, cost-effective, and scalable solutions. Their product portfolio includes user-friendly exosome isolation kits—ExoCAS™, ExoPAS™, ExoFilter™, and ExoTFF™—along with the miRQuick™ exosomal microRNA extraction kit. Beyond product development, Microgentas is advancing extracellular vesicle research focused on exosome-based biomarkers for breast cancer diagnosis and monitoring through a collaboration with Korea University Anam Hospital. The company also partners with cosmetic manufacturers seeking to incorporate exosomes as active ingredients in their formulations.

Contact us to explore solutions and pricing for your specific needs.